Outlook Therapeutics, Inc. reports

Company location: Iselin, NJ
Fiscal year end: 30 September

Outlook Therapeutics, Inc. has filed 815 SEC EDGAR filings since 10 Aug 2015

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 226-250 of 815 matching filings.

Per page

25

Current page

10

8-K File 001-37759

FORM 8-K

Filing date: 15 May 2023
Reporting date: 15 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 21 Apr 2023
Reporting date: 20 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Apr 2023
Reporting date: 17 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Apr 2023
Reporting date: 17 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Apr 2023
Reporting date: 17 Apr 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 001-37759

FORM 8-K/A

Filing date: 03 Apr 2023
Reporting date: 30 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 31 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37759

FORM 8-K

Filing date: 30 Mar 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-89495

OUTLOOK THERAPEUTICS, INC./JASON HOPE SCHEDULE 13G/A, AMENDMENT NO. 1

Filing date: 21 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

ARS File 001-37759

ARS

Filing date: 15 Feb 2023
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-37759

DEF 14A

Filing date: 15 Feb 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-269770

FORM S-8

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-37759

10-Q

Filing date: 14 Feb 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37759

FORM 8-K

Filing date: 14 Feb 2023
Reporting date: 14 Feb 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

PRE 14A File 001-37759

PRE 14A

Filing date: 27 Jan 2023
Reporting date: 29 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 Jan 2023
Reporting date: 20 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K/A File 001-37759

10-K/A

Filing date: 24 Jan 2023
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 Jan 2023
Reporting date: 17 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .